<

 
Data updated 2025-06-02 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date01939751.2 (espacenet)  (Federated)  (European Patent Register), 20010531
Patent/reg. no. and dateDK/EP 1229909, 20031112
Publication date20020814
Priority no. and dateUS 208789 P, 20000601
EP pub. no. and date EP 1229909 20020814
Effective date
Applicant/ownerWatson Pharmaceuticals, Inc., 311 Bonnie Circle
Corona, CA 92880, US
Applicant ref. no.108495
InventorFIKSTAD, David, 726 South Green Street
Salt Lake City, UT 84102, US,
QUAN, Danyi, 4156 South Meagan Circle
Salt Lake City, UT 84107, US
RepresentativeAWA Denmark A/S, Strandgade 56, 1401 København K, DK
Opponent
IPC Class A61K 9/00, A61K 9/70, A61P 5/30, A61K 31/40
TitleTransdermal indgivelse af lasofoxifen
Int. application no.US2001017567
Int. publication no.WO2001091724
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact